1. Home
  2. OCGN vs FSBW Comparison

OCGN vs FSBW Comparison

Compare OCGN & FSBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • FSBW
  • Stock Information
  • Founded
  • OCGN 2013
  • FSBW 1936
  • Country
  • OCGN United States
  • FSBW United States
  • Employees
  • OCGN N/A
  • FSBW N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • FSBW Banks
  • Sector
  • OCGN Health Care
  • FSBW Finance
  • Exchange
  • OCGN Nasdaq
  • FSBW Nasdaq
  • Market Cap
  • OCGN 321.7M
  • FSBW 296.6M
  • IPO Year
  • OCGN N/A
  • FSBW 2012
  • Fundamental
  • Price
  • OCGN $1.52
  • FSBW $39.01
  • Analyst Decision
  • OCGN Strong Buy
  • FSBW Hold
  • Analyst Count
  • OCGN 2
  • FSBW 1
  • Target Price
  • OCGN $7.00
  • FSBW $44.00
  • AVG Volume (30 Days)
  • OCGN 5.9M
  • FSBW 12.4K
  • Earning Date
  • OCGN 11-05-2025
  • FSBW 10-21-2025
  • Dividend Yield
  • OCGN N/A
  • FSBW 2.84%
  • EPS Growth
  • OCGN N/A
  • FSBW N/A
  • EPS
  • OCGN N/A
  • FSBW 4.08
  • Revenue
  • OCGN $4,754,000.00
  • FSBW $140,954,000.00
  • Revenue This Year
  • OCGN N/A
  • FSBW $9.62
  • Revenue Next Year
  • OCGN N/A
  • FSBW $5.35
  • P/E Ratio
  • OCGN N/A
  • FSBW $9.66
  • Revenue Growth
  • OCGN N/A
  • FSBW 1.07
  • 52 Week Low
  • OCGN $0.52
  • FSBW $34.61
  • 52 Week High
  • OCGN $1.90
  • FSBW $49.15
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 48.14
  • FSBW 47.68
  • Support Level
  • OCGN $1.47
  • FSBW $38.69
  • Resistance Level
  • OCGN $1.65
  • FSBW $40.53
  • Average True Range (ATR)
  • OCGN 0.11
  • FSBW 0.84
  • MACD
  • OCGN -0.03
  • FSBW 0.12
  • Stochastic Oscillator
  • OCGN 13.51
  • FSBW 52.28

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

Share on Social Networks: